Q

Qiagen NV
D

QGEN

43.110
USD
0.88
(2.08%)
مغلق
حجم التداول
59,183
الربح لكل سهم
2
العائد الربحي
-
P/E
113
حجم السوق
9,316,765,157
أصول ذات صلة
NEOUSD
NEOUSD
-0.08928
(-1.54%)
5.70171 USD
BDX
BDX
-0.770
(-0.45%)
168.780 USD
C
CRL
1.560
(1.34%)
118.410 USD
DGX
DGX
0.630
(0.36%)
178.000 USD
GILD
GILD
0.420
(0.41%)
103.660 USD
HOLX
HOLX
-3.060
(-5.35%)
54.180 USD
IQV
IQV
2.550
(1.69%)
153.420 USD
LH
LH
6.300
(2.61%)
247.700 USD
N
NEO
0.46000
(6.34%)
7.72000 USD
TMO
TMO
3.67
(0.87%)
423.51 USD
المزيد
الأخبار المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).